Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Consulting agrmnt Credit agrmnt [a] Appointed director Inv. presentation Quarterly results Director departure CC transcript
|
MIMEDX GROUP, INC. (MDXG)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/01/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/01/2023 |
8-K
| Quarterly results |
07/25/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
07/25/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
07/06/2023 |
4
| DOUG RICE (CFO) has filed a Form 4 on MIMEDX GROUP, INC.
Txns:
| Granted 97,200 shares
@ $0 Granted 94,000 options
@ $6.44, valued at
$605.4k
|
|
07/06/2023 |
3
| DOUG RICE (CFO) has filed a Form 3 on MIMEDX GROUP, INC. |
07/05/2023 |
8-K
| Quarterly results |
06/15/2023 |
4
| BIERMAN JAMES L (Director) has filed a Form 4 on MIMEDX GROUP, INC.
Txns:
| Granted 35,354 shares
@ $4.95, valued at
$175k
|
|
06/15/2023 |
4
| BEHRENS M KATHLEEN (Director) has filed a Form 4 on MIMEDX GROUP, INC.
Txns:
| Granted 35,354 shares
@ $4.95, valued at
$175k
|
|
06/15/2023 |
4
| GARDNER PHYLLIS (Director) has filed a Form 4 on MIMEDX GROUP, INC.
Txns:
| Granted 35,354 shares
@ $4.95, valued at
$175k
|
|
06/15/2023 |
4
| Giuliani Michael J (Director) has filed a Form 4 on MIMEDX GROUP, INC.
Txns:
| Granted 35,354 shares
@ $4.95, valued at
$175k
|
|
06/15/2023 |
4
| HAWKINS WILLIAM A (Director) has filed a Form 4 on MIMEDX GROUP, INC.
Txns:
| Granted 35,354 shares
@ $4.95, valued at
$175k
|
|
06/15/2023 |
4
| Newton Todd (Director) has filed a Form 4 on MIMEDX GROUP, INC.
Txns:
| Granted 35,354 shares
@ $4.95, valued at
$175k
|
|
06/15/2023 |
4
| LAURENCIN CATO T (Director) has filed a Form 4 on MIMEDX GROUP, INC.
Txns:
| Granted 35,354 shares
@ $4.95, valued at
$175k
|
|
05/17/2023 |
4
| Stein Robert Benjamin (President, Regenerative Med.) has filed a Form 4 on MIMEDX GROUP, INC.
Txns:
| Sold 3,607 shares
@ $6.1465, valued at
$22.2k
Sold 10,365 shares
@ $5.9457, valued at
$61.6k
|
|
05/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
05/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
05/15/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
05/12/2023 |
4
| Hulse William Frank IV (General Counsel and CAO) has filed a Form 4 on MIMEDX GROUP, INC.
Txns:
| Sold 5,870 shares
@ $5.9261, valued at
$34.8k
|
|
05/12/2023 |
4
| Stein Robert Benjamin (President, Regenerative Med.) has filed a Form 4 on MIMEDX GROUP, INC.
Txns:
| Sold 5,869 shares
@ $5.9261, valued at
$34.8k
|
|
05/12/2023 |
4
| Phelan William Lawrence (Chief Accounting Officer) has filed a Form 4 on MIMEDX GROUP, INC.
Txns:
| Sold 1,595 shares
@ $5.9261, valued at
$9.5k
|
|
05/12/2023 |
4
| Carlson Peter M (CFO) has filed a Form 4 on MIMEDX GROUP, INC.
Txns:
| Sold 5,976 shares
@ $5.9261, valued at
$35.4k
|
|
05/09/2023 |
4
| Stein Robert Benjamin (President, Regenerative Med.) has filed a Form 4 on MIMEDX GROUP, INC.
Txns:
| Sold 51,756 shares
@ $5.3418, valued at
$276.5k
|
|
05/04/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
05/04/2023 |
144
| Form 144 - Report of proposed sale of securities: |
05/03/2023 |
4
| Phelan William Lawrence (Chief Accounting Officer) has filed a Form 4 on MIMEDX GROUP, INC.
Txns:
| Sold 5,200 shares
@ $3.796, valued at
$19.7k
|
|
05/01/2023 |
10-K/A
| Annual Report for the period ended December 31, 2022 [amend] |
04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/25/2023 |
144
| Form 144 - Report of proposed sale of securities: |
04/25/2023 |
144
| Form 144 - Report of proposed sale of securities: |
04/25/2023 |
144
| Form 144 - Report of proposed sale of securities: |
|
|
|